Simple Drug Change Could Save Medicare Hundreds of Millions
Changing Alzheimer's drug vial size might save big money for Medicare
A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions of dollars each year, a new analysis claims.
Alzheimer's: Simple Drug Change Could Save Medicare Hundreds of Millions
Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication.
Change in Alzheimer's Drug Vial Size Could Be Big Money-Saver for Medicare
It is imperative to reduce spending on services that do not improve the health of patients, and this is a prime example of such, given that Medicare is paying for a drug only t
New Vial Size Could Save US Medicare Millions on Alzheimer's Breakthrough Drug Leqembi
New research suggests that Medicare could save up to 74 percent of the money lost from discarded Alzheimer's drug Leqembi or lecanemab by simply introducing a new vial size that would reduce the amount of unused medication thrown away.
Big vials of Alzheimer's drug could cost Medicare $336M
Medicare could be throwing away as much as $336 million worth of a costly Alzheimer's drug each year because the size of vials is too big, UCLA researchers estimate. Why it matters: The findings, published Monday in JAMA Internal Medicine,
Smaller vial for Alzheimer's drug could save Medicare $366M per year: Study
A new study suggests that Medicare could save up to $366 million annually by introducing a new vial size for Alzheimer's drug lecanemab, which is currently only available in single-use, 500- and 200-milligram vials.
Smaller vial size for Alzheimer's drug could save Medicare hundreds of millions per year
Medicare could save up to 74% of the money lost from discarded Alzheimer's drug lecanemab by the simple introduction of a new vial size that would reduce the amount of unused medication that is thrown away.
FiercePharma1d
Leqembi's vial design could result in hundreds of millions in annual Medicare waste: study
Since Leqembi is dosed based on a patient’s weight and offered in single-use vials, about 5.8% of the drug dispensed will be ...
The American Journal of Managed Care2d
Discarded Lecanemab Leads to Medicare Drug Waste of Up to $336 Million
Lecanemab (Leqembi; Eisai/Biogen) received traditional approval from the FDA in July 2023, following an accelerated approval ...
kffhealthnews1d
Medicare Open Enrollment Kicks Off: Be Aware Of Plan Changes For 2025
Enrollment in a 2025 Medicare plan opened for beneficiaries today. News outlets focus on an array of changes that could lead to "benefit disruption" that consumers should know about, in particular ...
NerdWallet21d
Medicare Is Changing in 2025 — Why You Should Care (and Shop)
This year's Medicare open enrollment season is extra important due to changes that will impact 2025 Medicare Part D and Medicare Advantage plans. Many, or all, of the products featured on this ...
MarketWatch4d
4 things you need to know about Medicare drug costs and coverage in 2025
With Medicare prescription-drug benefits on the brink of a shake-up, enrollees who hope to minimize their costs at the pharmacy counter next year need to stay vigilant in the coming months.
CNET4d
Medicare Open Enrollment Is Around the Corner: What You Need to Know
Whether you're looking to join original Medicare or Medicare Advantage, the next few months are the time to do it. Thomas is a native of upstate New York and a graduate of the University at Albany ...
CBS News7d
Kamala Harris proposes Medicare pay for more in-home health care during appearance on "The View"
Vice President Kamala Harris said Tuesday that she intends for Medicare to pay for long-term, in-home health care for a broader group of seniors, something she says the program will pay for ...
Kiplinger3d
Medicare or Medicare Advantage: Which Is Right for You?
Medicare’s annual enrollment period is around the corner, running from October 15 to December 7 each year. This is the time when Medicare beneficiaries can decide to enroll in a Medicare ...